About Alvotech
Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars.
Alvotech (ALVO) Stock Score & Signals
Alvotech (ALVO) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 36 out of 100.
2BB score and signals
Alvotech’s current 2BB score is 36 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 34 | Low |
| Momentum | 50 | Stable |
| Financial strength | 24 | Weak |
| Quality | 92 | Very Strong |
| Risk | 63 | High (provisional) |
Company facts
| Founded | 2013 |
| Employees | 1.28K |
| 52-week range | $2.94 – $6.53 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-05-04 | — | -0.0306 | — | $174.46M |
| 2027-03-10 | — | 0.187 | — | $265.16M |
| 2026-11-11 | — | -0.0476 | — | $121.42M |